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Abstract
Background: Community clinics offer potential for timelier outbreak detection and monitoring than emergency
departments. However, the accuracy of syndrome definitions used in surveillance has never been evaluated in
community settings. This study’s objective was to assess the accuracy of syndrome definitions based on diagnostic
codes in physician claims for identifying 5 syndromes (fever, gastrointestinal, neurological, rash, and respiratory
including influenza-like illness) in community clinics.
Methods: We selected a random sample of 3,600 community-based primary care physicians who practiced in the
fee-for-service system in the province of Quebec, Canada in 2005-2007. We randomly selected 10 visits per
physician from their claims, stratifying on syndrome type and presence, diagnosis, and month. Double-blinded
chart reviews were conducted by telephone with consenting physicians to obtain information on patient
diagnoses for each sampled visit. The sensitivity, specificity, and positive predictive value (PPV) of physician claims
were estimated by comparison to chart review.
Results: 1,098 (30.5%) physicians completed the chart review. A chart entry on the date of the corresponding
claim was found for 10,529 (95.9%) visits. The sensitivity of syndrome definitions based on diagnostic codes in
physician claims was low, ranging from 0.11 (fever) to 0.44 (respiratory), the specificity was high, and the PPV was
moderate to high, ranging from 0.59 (fever) to 0.85 (respiratory). We found that rarely used diagnostic codes had a
higher probability of being false-positives, and that more commonly used diagnostic codes had a higher PPV.
Conclusions: Future research should identify physician, patient, and encounter characteristics associated with the
accuracy of diagnostic codes in physician claims. This would enable public health to improve syndromic
surveillance, either by focusing on physician claims whose diagnostic code is more likely to be accurate, or by
using all physician claims and weighing each according to the likelihood that its diagnostic code is accurate.
Background
Syndromic surveillance is used widely by public health
departments to detect and monitor unusual disease
activity in the population by extracting nonspecific clini-
cal data from information systems in clinical settings
[1-4]. Whereas much syndromic surveillance practice [3]
and research [5] has focused on visits to emergency
departments (ED), visits to community clinics offer
another promising source of data. Syndromes followed
in practice, such as influenza-like-illness (ILI), typically
involve earlier, milder stages of disease, and most
affected persons are likely to self-treat [6-8], at least
initially, or present to walk-in clinics [6]. In fact,
researchers have demonstrated that excess ILI activity
can be detected earlier using data from clinics as com-
pared to data from EDs [9-11]. The accuracy of diagnos-
tic data from community clinics has not, however, been
established.
Many syndromic surveillance systems use Interna-
tional Classification of Disease, 9
th revision (ICD-9)
diagnostic codes in administrative databases to monitor
syndrome occurrence [12]. For this purpose, expert
panels have generated groupings of ICD-9 codes corre-
sponding to conceptual syndrome definitions [13].
Administrative databases offer great promise for popula-
tion-based surveillance by providing access to diagnostic
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healthcare settings. However, unlike medical procedure
codes, ICD-9 diagnostic codes are not usually linked to
healthcare provider payment, and therefore are not
audited by health administrative authorities. Because of
this, variation in diagnostic coding between physicians
and between institutions is expected.
In a pilot study [14], we evaluated the accuracy of
diagnostic codes in physician claims for identifying
acute respiratory infections in nine Montreal-area com-
munity-based physicians. We abstracted the diagnosis
from the medical chart for the 3,526 visits made by 729
sampled patients in 2002-2005, and compared the medi-
cal chart diagnosis to the ICD-9 code on the corre-
sponding physician claim. For all acute respiratory
infections combined, we found a sensitivity of 0.49, 95%
CI (0.45, 0.53), and a positive predictive value (PPV) of
0.93, 95% CI (0.91, 0.94). These pilot study results are
promising, but there is a need for a large-scale, popula-
tion-based investigation of the accuracy of diagnostic
codes used in syndromic surveillance.
The objective of the present study was to assess the
accuracy of syndrome definitions based on diagnostic
codes from a representative sample of physician claims
for identifying 5 syndromes (fever, gastrointestinal, neu-
rological, rash, and respiratory, including influenza-like
illness (ILI)) in community healthcare settings. These
syndromes were selected for their relevance to public
health and the likelihood of being first detected among
patients presenting to community healthcare settings.
Methods
Context
This study was conducted in the province of Quebec,
Canada, where universal health coverage is provided
through the provincial health insurance plan. Each
Canadian province maintains a population-based registry
of insured persons and claims for all physician visits
remunerated on a fee-for-service basis. Physician claims
include information on the diagnosis (recorded as an
ICD-9 code), medical procedure, visit date, location, and
cost of service. All claims also record unique physician
and patient identifiers that can be used to create longi-
tudinal histories of healthcare use. In the province of
Quebec, 99% of residents have provincial health insur-
ance and 85-95% of medical visits are remunerated on a
fee-for-service basis [15]. In 2006, there were more than
7.6 million inhabitants in Quebec [16], and 18,908 active
registered physicians [17]. The availability of diagnostic
information for nearly all medical visits to Quebec phy-
sicians represents an invaluable opportunity for asses-
sing the validity of using diagnostic codes in physician
claims for population-based surveillance, including syn-
dromic surveillance.
Study design and sampling
The accuracy of diagnostic codes in physician claims for
identifying syndromes was assessed by comparison to
clinical information in the corresponding medical chart.
To ensure representativeness, we used a population-
based, 3-stage stratified random sample of 36,000 visits
(Figure 1). In the first stage (Figure 1 Stage 1), the pro-
vincial health insurance agency identified all physicians
who were eligible to be included in our study. To be eli-
gible, physicians had to be a general practitioner, pedia-
trician, internist, geriatrician or general surgeon who
practiced in the fee-for-service system in a private clinic,
community health center, or hospital-based ambulatory
care clinic during the 2-year study period (October 1,
2005 to September 30, 2007). Internists and general sur-
geons were included in our sample because, especially
in rural-remote and underserved areas, these physicians
may provide first-contact care and act as patients’ family
physician. From the 8,700 eligible physicians identified,
the provincial health insurance agency selected a ran-
dom sample of 3,600 (41.4%) physicians.
8,700 eligible physicians
Stage 1: simple random sample of 3,600 
(41.4%) eligible physicians
3,600 sampled physicians
Stage 2: simple random sample of 1 
eligible practice location per physician
3,600 physician practice locations
Stage 3: random sample of 10 visits per 
physician practice location:
 5 visits negative for all syndromes
 1 visit positive for each of the 5 
syndromes (fever, gastrointestinal, 
neurological, rash, and respiratory 
including influenza-like illness).
 For each syndrome, the sample of 
syndrome-positive visit was further 
stratified by ICD-9 code.
Exclusion was used to ensure each patient 
was sampled only once.
Syndrome-negative visits were frequency-
matched on month to syndrome positive 
visits to avoid seasonal bias.
36,000 visits to be verified
Figure 1 Population-based, 3-stage stratified random sample
of visits to all community physicians in the province of
Quebec.
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chart retrieval for review, the health insurance agency
randomly selected one eligible community practice loca-
tion for each physician. The health insurance agency
then sent the research team an anonymized file contain-
ing all physician claims billed by the 3,600 physicians
from their respective selected community practice loca-
tion during the 2-year study period (Figure 2 Step 1).
In the third stage (Figure 1 Stage 3), the research team
randomly selected 5 syndrome-positive visits, i.e., 1 visit
for each of fever, gastrointestinal, neurological, rash, and
respiratory syndrome (including ILI), and 5 visits nega-
tive for all syndromes. Visits were classified as positive
for a syndrome if a physician claim for the visit had an
I C D - 9c o d et h a tw a sp a r to ft h es y n d r o m ed e f i n i t i o n .
Because syndromes have low population prevalence,
to maximize data collection efficiency [18], syndrome-
positive visits were over-sampled relative to syndrome-
negative ones, so as to yield 1 syndrome-positive visit per
syndrome per physician and 5 syndrome-negative visits
per physician. When sampling syndrome-positive claims,
to maximize the number of syndrome-positive ICD-9
codes verified, we further stratified on ICD-9 code.
Because two or more syndromes can occur concurrently
in the same patient [19], syndrome-negative visits were
negative for all syndromes. Syndrome-negative visits
were also matched to syndrome-positive visits on calen-
dar month to avoid bias due to syndrome seasonality. To
avoid bias due to visits being clustered within patients,
restriction was used to ensure that each patient was only
sampled once. The list of 10 sampled visits was enumer-
ated for each of the 3,600 physicians, for a total of 36,000
visits. An anonymized unique identifier, the study num-
ber, was assigned to each sampled visit by the research
team. The list of 36,000 sampled visits was then sent to
the health insurance agency (Figure 2 Step 2).
Syndrome definitions
We verified two sets of definitions for the 5 syndromes
under study: the definitions developed and published by
the US Centers for Disease Control and Prevention
(CDC) in 2003 [13], and used by the US Department of
Defense’s (DoD) Electronic Surveillance System for Early
Notification of Community-based Epidemics (ESSENCE),
as well as the corresponding definitions in the University
of Pittsburgh’s Real-time Outbreak and Disease Surveil-
lance (RODS) system [19]. For ILI, we used the large-
group (sensitive) and small-group (specific) definitions
developed for the DoD ESSENCE system [20]. These
definitions are similar to the consensus syndrome defini-
tions being developed by representatives from the
10 syndromic surveillance systems in place in the
US [21], which have not yet been mapped to ICD-9 codes.
Physician recruitment
To preserve physician and patient anonymity, the health
insurance agency sent the list of 3,600 physicians and
36,000 visits sampled by the research team to the medi-
cal regulatory authority (Figure 2 Step 3). The medical
regulatory authority has the legal right to access confi-
dential physician and patient information, therefore the
list it received included physician names and mailing
addresses, as well as patient names, insurance numbers,
and dates of birth. The medical regulatory authority
acted as a trusted third party and recruited physicians to
the study on behalf of the research team; it also pro-
vided physicians with information on the 10 sampled
visits (Figure 2 Step 4). Interested physicians mailed
their written consent and contact information to the
research team (Figure 2 Step 5). Non-responding physi-
cians were sent up to four reminders. Physician recruit-
ment began in September 2008 and ended in August
2009. To maximize participation, physicians were
offered $50 compensation for their participation and a
summary of study findings.
Physician-facilitated medical chart review
The medical regulatory authority sent each physician the
list of 10 sampled visits (Figure 2 Step 3). Lists sent to
physicians included patients’ first and last names, date
of birth, health insurance number, and date of the visit
to be verified, as well as the study number for each visit.
Because the lists sent to physicians contained both
patient information and study numbers, it enabled phy-
sicians to retrieve the relevant medical charts, and
researchers to link the information collected through
chart review to the anonymized physician claims file.
During the chart review, interviewers and physicians
 
Quebec 
health 
insurance 
agency 
 
McGill 
University 
research 
team 
 
 Physicians in 
community 
clinics 
 
Quebec 
medical 
regulatory 
authority 
Step 1: Health insurance 
agency sends anonymized 
physician claims from 3,600 
randomly-sampled physicians* 
to research team 
Step 4: Medical regulatory 
authority recruits physicians 
to study, sends info on 10 
sampled visits to each 
physician 
Step 5: 
Physicians 
provide written 
consent to 
research team 
Step 6: 
Physician-
facilitated 
medical chart
review 
Step 3: Health 
insurance agency 
sends info on 3,600 
physicians and 36,000 
visits to medical 
regulatory authority 
Step 2: Research team 
samples 10 visits per 
physician** and sends them 
to health insurance agency 
Figure 2 Overview of data collection * Physician sampling by the
Quebec health insurance agency is described in Figure 1, Stages 1
and 2. ** Visit sampling by the research team is described in Figure
1, Stage 3.
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visit date, thereby preserving patient anonymity.
Physician-facilitated medical chart reviews began in
September 2008 and ended in December 2009. Using a
previously published methodology [22], trained inter-
viewers contacted consenting physicians by telephone to
perform the chart review (Figure 2 Step 6). For each of
the 10 sampled visits, the interviewer asked the physi-
cian to list all diagnoses. For each diagnosis correspond-
ing to a syndrome definition, the interviewer asked the
physician about the signs, symptoms, and key findings
recorded in the medical chart, as well as the most likely
etiology for the diagnosis (based solely on information
available at the time of the visit).
Physician responses were entered directly into a data-
base by the interviewer. Diagnoses were selected from a
searchable list of diagnoses (mapped to ICD-9 codes) or,
if the physician had recorded the ICD-9 code in the
medical chart, the ICD-9 code was entered directly. For
each syndrome-positive diagnosis, a list of syndrome-
specific signs and symptoms was elicited, and the inter-
viewer recorded whether the sign or symptom had been
present, absent, or not recorded in the medical chart.
Symptoms or signs not in the list and other key find-
ings, such as epidemiologic links to other diagnosed
cases or known outbreaks, were recorded as free text in
separate fields. The data collection tool was translated
to French for use with French-speaking physicians, and
back-translated to English to ensure comparability of
data collection.
At the time of chart review, the physician and inter-
viewer were both blinded to the ICD-9 code in the phy-
sician claim and the syndrome-positive or syndrome-
negative status of the claim. To minimize measurement
error due to inter-rater differences, interviewers were
trained to use the data collection tool. Inter-rater relia-
bility was assessed at baseline by having interviewers
perform 2 simulated physician interviews of 10 visits
each (for a total of 20 visits). To maintain data quality,
interviewers underwent quality assurance monitoring
every 3 months. Each assessment was comprised of 2
simulated physician interviews of 10 visits each (for a
total of 20 visits). Agreement between raters was mea-
sured using the intraclass correlation coefficient (ICC).
Linkage of the medical chart review data to the physician
claims data
The database containing the medical chart review data
was linked to the physician claims file using the study
number, physician identifier, and visit date. In our pilot
study [14], we found that the visit date in the chart
sometimes differed slightly from the visit date on the
claim. We considered the chart and the claim to refer to
the same visit if the visit date in the chart was within 0
(identical date) to 3 days from the visit date in the
claim.
Physician characteristics that may influence participation
Physician gender, preferred language (French or Eng-
lish), specialty, practice setting, and geographic location
were obtained from the health insurance agency. Physi-
cian year of licensure was obtained from the medical
regulatory authority. The number of days worked per
year was calculated as the number of days when at least
one claim was billed by the physician to the health
insurance agency. The number of patients seen per day
worked was calculated as the number of distinct patients
for which one or more claim was billed by the physician
per day worked. The number and prevalence of syn-
drome-positive visits were calculated for each physician
using claims billed from the selected practice location
during the 2-year study period.
Statistical methods
For each visit, we assessed if the ICD-9 code in the phy-
sician claim and the diagnosis in the corresponding
medical chart agreed as to the presence of each syn-
dromes and ILI. For example, if the diagnosis in the
claim was cough (786.2) and the diagnosis in the corre-
sponding medical chart was acute bronchitis (466.0),
then both the claim diagnosis and the chart diagnosis
were positive for respiratory syndrome, therefore the
claim was a true-positive for respiratory syndrome. If
the diagnosis in the claim was cough (786.2) and the
diagnoses in the chart were hypertension (401.9) and
diabetes (250.0), then the claim diagnosis was positive
for respiratory syndrome and the chart diagnoses were
not, therefore the claim was a false-positive for respira-
tory syndrome.
The negative predictive value (NPV) of each syndrome
definition was estimated directly from the data. Because
we stratified syndrome-positive visits by ICD-9 code, we
had to use an adjustment based on Bayes Theorem [23]
to estimate the PPV of each syndrome. The PPV was
estimated as a weighted average of each ICD-9 code’s
PPV, the weight being the number of visits with a given
ICD-9 code divided by the total number of visits posi-
tive for that syndrome among participating physicians.
Because we verified more syndrome-positive visits
than syndrome-negative ones, direct estimation of sensi-
tivity and specificity using our data would lead to verifi-
cation bias: sensitivity would be overestimated, and
specificity underestimated [23]. Because verified claims
were randomly sampled within syndrome-positive and
syndrome-negative strata, unbiased estimation of these
parameters was achieved by re-weighting for the verifi-
cation fractions [23]. The sensitivity and specificity of
physician claims for identifying each syndrome was
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tion for verification bias [23], re-weighting for the differ-
ent sampling fractions. We estimated the 95% CI for the
bias-corrected sensitivity and specificity using the meth-
ods described by Begg and Greenes [23].
Ethics review
The research protocol for this study was reviewed and
approved by the McGill University Institutional Review
Board, the Quebec privacy commission (Commission
d’accès à l’information du Québec), the legal department
of the Quebec health insurance agency (Régie de l’assur-
ance maladie du Québec), and the Quebec medical reg-
ulatory authority (Collège des médecins du Québec).
Results
Between October 1, 2005 and September 30, 2007, the
3,600 study physicians billed for over 20 million visits
by 4.8 million patients (61% of the province’sp o p u l a -
tion) from their randomly selected community practice.
Physician participation
Of 3,600 physicians contacted, 172 (4.8%) had an incor-
rect address on file with the health insurance agency, and
170 (4.7%) were discovered to be ineligible (recently
deceased, retired, on sick/maternity leave, no longer
practicing at the selected practice location). Of the 3,258
remaining physicians, 1,129 (34.7%) physicians consented
to participate in the study, 218 (6.7%) refused, and 1,911
( 5 8 . 7 % )d i dn o tr e s p o n d .O ft he 1,129 consenting physi-
cians, 1,098 (97.3%) completed the physician-facilitated
medical chart review, and 31 (2.7%) were unreachable or
withdrew consent prior to interview. Participating and
non-participating physicians were similar on all measured
variables except two (Table 1): as compared to non-parti-
cipants, participants had been in practice longer and had
worked more days during the study period. Syndrome
prevalence was similar among participating and non-
participating physicians, and ranged from 5 per 1,000
visits for neurological syndrome and ILI small-group, to
126 per 1,000 visits for respiratory syndrome.
Inter-rater agreement
Agreement between raters was measured using simu-
lated physician interviews shortly before the start of data
collection and every 3 months thereafter. Agreement
was perfect on all assessments (ICC = 1.00).
Date agreement between the claim and the medical chart
Of the 10,980 visits selected for verification (10 visits
per participating physician), physicians were able to
access the corresponding medical chart for 10,669
(97.2%). The most common reasons for being unable to
access the chart were inability to locate the medical
chart (151 charts) and medical chart in storage with
retrieval fee (140 charts). For 10,465 (98.1%) of the
sampled visits, the visit datei nt h em e d i c a lc h a r tw a s
identical to the visit date on the claim. Allowing for
potential date transcription errors during billing, an
additional 64 (0.6%) visits with a date in the medical
chart that was within 1-3 days of the visit date on the
claim were identified, for a total of 10,529 visits for
which both the medical chart and the claim was avail-
able and the visit dates were in agreement (within the
3 day time window).
Syndrome agreement between the claim ICD-9 code and
the medical chart diagnosis
Table 2 shows the accuracy of ICD-9 codes in physician
claims for identifying syndromes, as compared to the
medical chart. The sensivity of ICD-9 codes in physician
claims for identifying syndromes was low, ranging from
0.11, 95% CI (0.10, 0.13) for fever syndrome to 0.44,
95% CI (0.41, 0.47) for respiratory syndrome. The PPV
of ICD-9 codes in physician claims for identifying syn-
dromes was moderate to high, ranging from 0.59, 95%
CI (0.55, 0.64) for fever syndrome to 0.85, 95% CI (0.83,
0.88) for respiratory syndrome. Both the specificity and
NPV of ICD-9 codes in physician claims were near-per-
fect for all syndromes studied.
Additional file 1 (excerpted in Table 3) shows the PPV
of physician claims for identifying syndromes for each
ICD-9 code individually. There was wide variation in
PPV between different ICD-9 codes in a given syn-
drome. ICD-9 codes that were very rarely used by physi-
cians, for example tularemia (ICD-9 code: 21.9), had a
high probability of being false-positives, and therefore a
very low PPV. ICD-9 codes for common symptoms, for
example fever (ICD-9 code: 780.6), had a lower prob-
ability of being false-positives, and a higher PPV. ICD-9
codes that represent common diagnoses, for example
acute bronchitis (ICD-9 code: 466.0), had the lowest
probability of being false-positives, and the highest PPV.
Discussion
T h i ss t u d yw a st h ef i r s tl a r g e-scale, population-based
investigation of the accuracy of syndrome definitions
based on diagnostic codes in physician claims from
community healthcare settings. We found that the sensi-
tivity of syndrome definitions based on diagnostic codes
in physician claims for identifying syndromes was low,
the PPV was moderate to high, and the specificity and
NPV were near-perfect. Even though our sensitivity esti-
mates were low for all syndromes definitions, these syn-
drome definitions may still be useful for monitoring
syndrome occurrence when there are large numbers of
cases (e.g., seasonal influenza). Respiratory syndrome
had the highest prevalence and was the most accurately
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Participating physicians (N = 1,098) Non-participating physicians (N = 2,160)
Physician characteristics No. (%) No. (%)
Gender:
Female 411 37.4 823 38.1
Male 687 62.6 1,337 61.9
Preferred language:
French 1,006 91.6 1,937 89.7
English 92 8.4 223 10.3
Specialty:
General practice 993 90.4 1,932 89.4
Internal medicine 13 1.2 41 1.9
Pediatrics 62 5.6 102 4.7
General surgery 30 2.7 85 3.9
Geriatrics 0 0 0 0
Type of setting selected:
1
Private clinic 1,060 96.5 2,044 94.6
Community health center 5 0.5 9 0.4
Hospital-based
ambulatory clinic
33 3.0 107 5.0
Geographic location of selected setting:
1,3
Urban 921 83.9 1,867 86.4
Rural 177 16.1 293 13.6
Mean SD Mean SD
Years since licensure 24.2 9.7 22.3 10.5
No. days worked per year
1 157.0 55.0 143.2 59.8
No. patients seen per day worked
1 21.2 13.4 21.0 13.3
Syndrome frequency based on claim ICD-9 code No. visits
1,2 Prevalence
per 1,000 visits
1
No. visits
1,2 Prevalence
per 1,000 visits
1
CDC and DoD ESSENCE
4
Fever 80,884 11 160,821 12
Gastrointestinal 162,282 22 309,209 24
Neurological 40,236 5 73,810 6
Rash 126,900 17 224,370 17
Respiratory 911,924 125 1,643,240 126
RODS
5
Fever 162,000 22 291,990 22
Gastrointestinal 146,355 20 283,578 22
Neurological 36,344 5 67,344 5
Rash 55,251 8 103,698 8
Respiratory 478,201 65 877,556 67
Influenza-like illness
6
Large-group 622,046 85 1,129,782 87
Small-group 32,173 4 61,127 5
1 As per our study design, for each physician, a single practice location was randomly selected to facilitate the validation process. The information in this table is
based in claims generated from the selected practice location during the 2-year study period.
2 There were a total of 7,315,994 visits to the 1,098 participating physicians, and 13,010,410 visits to the 2,160 eligible non-participating physicians at the
selected practice location during the 2-year study period.
3 We tested the statistical significance (at the p < 0.05 level) of any differences between participating and non-participating physicians using a multivariate
logistic regression model where the dependent variable was participation and the independent variables were all characteristics in Table 1. Due to overlap
between CDC, RODS, and ILI syndrome definitions, to avoid collinearity, we used separate models for each set of syndrome definitions. As compared to non-
participating physicians, participating physicians had been in practice longer (odds ratio (OR)per 10 years since licensure, 1.15; 95% CI, 1.05-1.25), had worked more
days (ORper 50 days, 1.18; 95% CI, 1.09-1.28) during the 2-year study period.
4 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of
Defense’s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
5 Syndrome case definitions developed in the context of the University of Pittsburgh’s Real-time Outbreak and Disease Surveillance (RODS) system.
6 Syndrome case definitions developed in the context of the US Department of Defense’s Electronic Surveillance System for Early Notification of Community-
based Epidemics (ESSENCE).
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group had the lowest PPV of all syndromes definitions
studied, much lower than previously reported by others
[20]. The small-group definition of ILI is made up of
only four ICD-9 codes: influenza with pneumonia
(487.0), influenza with other respiratory manifestations
(487.1), influenza with other manifestations (487.8), and
acute upper respiratory infection, other multiple sites
(465.8). Based on our interviews of over a thousand
community physicians, we think that the poor accuracy
of the ILI small-group definition reflects the common
usage of the word ‘flu’ to describe a vague illness or a
combination of non-specific symptoms. In addition to
observing variation in physician claim accuracy between
syndromes, we also found large variation in accuracy
and prevalence between diagnostic codes within syn-
dromes. Diagnostic codes with a very low prevalence
were generally more likely to be false-positives; conver-
sely, diagnostic codes with a higher prevalence were
generally less likely to be false-positives, especially if
they represented a diagnosis, as opposed to a symptom.
This suggests that physicians are more likely to know
the correct diagnostic code for a frequently diagnosed
ailment, as compared to a rare one.
Rigorous attempts to assess the accuracy of ICD-9
codes used in syndromic surveillance as compared to
the medical chart have been few, and they have relied
on small convenience samples of emergency depart-
ments. In one such study, the accuracy of ICD-9 codes
in ED reports for identifying 3 syndromes (fever, gastro-
intestinal, and respiratory) was assessed as compared to
hospital chart diagnoses in the context of the US DoD
ESSENCE surveillance system [25]. For greater data col-
lection efficiency, syndrome-positive ED reports were
over-sampled relative to syndrome-negative ones; how-
ever, analyses were not adjusted for this differential sam-
pling strategy, resulting in verification bias [23], and
leading to a large overestimation of sensivity and under-
estimation of specificity. To illustrate, the proportion of
fever-positive visits in the sample was 0.19, whereas the
proportion of fever-positive visits in the population is
approximately 0.01 (based on our study). The authors
reported a sensitivity of 0.69 and a specificity of 0.95.
However, adjusting for verification bias, the estimates
would be approximately 0.09 for sensivity and 1.00 for
specificity, which is similar to our results. In another
study, the accuracy of ICD-9 codes in ED reports for
identifying 7 syndrome definitions (botulinic, constitu-
tional, gastrointestinal, hemorrhagic, neurological, rash,
and respiratory) was assessed against hospital chart diag-
noses in the context of the RODS surveillance system [19].
To maximize the quantity of syndrome-positive ICD-9
codes verified, the investigators selected a random sample
of syndrome-positive visits from ED reports, stratified on
Table 2 Accuracy of ICD-9 coded diagnoses in physician claims, as compared to ICD-9 coded diagnoses from
physician-facilitated medical chart review, for identifying constitutional, gastrointestinal, neurological, rash, and
respiratory syndrome, as well as influenza-like illness (ILI) (N = 10,529 visits with matched claim-record pair)
Syndrome definition No.
visits in verified
claims
No.
visits in verified
charts
Sensivity (95%
CI)
Specificity (95%
CI)
PPV (95% CI) NPV (95% CI)
CDC and DoD
ESSENCE
1
Fever 601 656 0.11 (0.10, 0.13) 0.99 (0.99, 0.99) 0.59 (0.55, 0.64) 0.94 (0.93, 0.95)
Gastrointestinal 855 888 0.23 (0.20, 0.26) 0.99 (0.99, 0.99) 0.71 (0.66, 0.75) 0.94 (0.94, 0.95)
Neurological 971 693 0.17 (0.14, 0.21) 1.00 (1.00, 1.00) 0.67 (0.64, 0.70) 0.98 (0.98, 0.98)
Rash 897 905 0.20 (0.18, 0.23) 0.99 (0.99, 0.99) 0.66 (0.62, 0.70) 0.95 (0.95, 0.96)
Respiratory 1,049 1,779 0.44 (0.41, 0.47) 0.97 (0.96, 0.98) 0.85 (0.83, 0.88) 0.84 (0.83, 0.85)
RODS
2
Fever 873 961 0.14 (0.12, 0.16) 0.99 (0.99, 0.99) 0.60 (0.56, 0.64) 0.91 (0.90, 0.92)
Gastrointestinal 703 834 0.20 (0.18, 0.23) 0.99 (0.99, 0.99) 0.68 (0.63, 0.73) 0.94 (0.94, 0.95)
Neurological 874 523 0.16 (0.13, 0.20) 1.00 (1.00, 1.00) 0.52 (0.48, 0.55) 0.99 (0.98, 0.99)
Rash 814 718 0.12 (0.10, 0.14) 1.00 (1.00, 1.00) 0.63 (0.59, 0.66) 0.96 (0.96, 0.97)
Respiratory 665 1,209 0.29 (0.26, 0.32) 0.98 (0.98, 0.98) 0.74 (0.70, 0.79) 0.87 (0.86, 0.88)
Influenza-like illness
3
Large-group 653 1,232 0.38 (0.35, 0.41) 0.98 (0.98, 0.98) 0.77 (0.73, 0.81) 0.88 (0.87, 0.89)
Small-group 53 49 0.18 (0.12, 0.26) 1.00 (1.00, 1.00) 0.29 (0.16, 0.41) 0.99 (0.99, 0.99)
1 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of
Defense’s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
2 Syndrome case definitions developed in the context of the University of Pittsburgh’s Real-time Outbreak and Disease Surveillance (RODS) system.
3 Syndrome case definitions developed in the context of the US Department of Defense’s Electronic Surveillance System for Early Notification of Community-
based Epidemics (ESSENCE).
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Page 7 of 10syndrome-positive ICD-9 code, such that an equal number
of syndrome-positive visits was sampled for each ICD-9
code in a syndrome. For example, fever (780.6) and bubo-
nic plague (020.0), both corresponding to constitutional
syndrome, contributed the same number of cases. How-
ever, the prevalence and accuracy of each ICD-9 code in a
syndrome is different, and because the analyses were not
adjusted for the uniform sampling strategy used, the
reported estimates of sensitivity, specificity, PPV and NPV
are biased. In a third study [26], the accuracy of ICD-9
coded physician diagnoses from 9 hospital EDs for identi-
fying ‘acute respiratory illness’ was assessed by comparison
to medical chart review. A simple random sample was
used; therefore the results were not subject to verification
bias. The authors reported a sensitivity of 0.43, 95% CI
(0.28-0.58) for acute respiratory illness, which is almost
identical to our sensitivity estimate for respiratory syn-
drome; their estimates of NPV and specificity were also
similar to ours, but their PPV estimate of 0.45, 95% CI
(0.29-0.61) is much lower than ours.
Our study had several strengths and limitations. We
used a large population-based random sample of all phy-
sicians working in the fee-for-service system in commu-
nity healthcare settings in the province of Quebec in
2005-2007, thereby capturing potential ICD-9 coding dif-
ferences between physicians, institutions, and regions.
Not only did we estimate the accuracy of syndrome defi-
nitions, as others have done, but our study design
enabled us to estimate the PPV of individual diagnostic
codes within each syndrome definition. Matching syn-
drome-negative visits to syndrome-positive visit on calen-
dar month ensured that our results were not affected by
seasonal bias. Because two or more syndromes can occur
concurrently in the same person [19], our requirement
that syndrome-negative visits be negative for all syn-
dromes ensured that we did not overestimate false-
Table 3 Example of diagnostic codes with the highest and lowest positive predictive value (excerpted from additional
file 1)
Example of diagnostic codes with the HIGHEST positive predictive value (PPV)
Syndrome ICD-9 code Diagnostic label PPV (95% CI)
Fever
1 82.8 Tick-borne rickettsiosis not elsewhere classified 1.00 (1.00, 1.00)
88.8 Other specified arthropod-borne diseases 1.00 (1.00, 1.00)
Gastrointestinal
1 7.1 Giardiasis 1.00 (1.00, 1.00)
5.9 Food poisoning not otherwise specified 1.00 (1.00, 1.00)
Neurological
1 323.0 Encephalitis in viral disease classified elsewhere 1.00 (1.00, 1.00)
784.3 Aphasia 1.00 (1.00, 1.00)
Rash
1 53.8 Herpes zoster with unspecified complication 1.00 (1.00, 1.00)
695.2 Erythema nodosum 1.00 (1.00, 1.00)
Respiratory
1 33.0 Bordetella pertussis 1.00 (1.00, 1.00)
462.9 Pharyngitis, acute not otherwise specified 1.00 (1.00, 1.00)
ILI large-group
2 487.0 Influenza with pneumonia 1.00 (1.00, 1.00)
486.0 Pneumonia, organism not otherwise specified 1.00 (1.00, 1.00)
Example of diagnostic codes with the LOWEST positive predictive value (PPV)
Syndrome ICD-9 code Diagnostic label PPV (95% CI)
Fever
1 88.0 Bartonellosis 0.00 (0.00, 0.00)
78.2 Sweating fever 0.00 (0.00, 0.00)
Gastrointestinal
1 555.0 Regional enteritis, small intestine 0.00 (0.00, 0.00)
1.1 Cholera due to Vibrio cholerae El Tor 0.00 (0.00, 0.00)
Neurological
1 323.2 Encephalitis in protozoal disease classified elsewhere 0.00 (0.00, 0.00)
53.0 Herpes zoster with meningitis 0.00 (0.00, 0.00)
Rash
1 51.0 Cowpox 0.00 (0.00, 0.00)
55.8 Measles complications not otherwise specified 0.00 (0.00, 0.00)
Respiratory
1 20.4 Secondary pneumonic plague 0.00 (0.00, 0.00)
79.8 Hantavirus infection 0.00 (0.00, 0.00)
ILI large-group
2 490.0 Bronchitis not otherwise specified 0.00 (0.00, 0.00)
465.8 Acute upper respiratory infection, other multiple sites 0.36 (0.08, 0.65)
1 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of
Defense’s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
2 Syndrome case definition developed in the context of the US Department of Defense’s Electronic Surveillance System for Early Notification of Community-based
Epidemics (ESSENCE).
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Page 8 of 10negatives and underestimate sensitivity and NPV. Our
participation rate, though low, was consistent with that
of other large population-based studies of Canadian
physicians [27,28]. Participating and non-participating
physicians were similar on nearly all measured variables.
The participation rate was significantly lower among
recently licensed physicians; recently licensed physicians
m a yh a v eb e e nl e s sl i k e l yt op a r t i c i p a t ei no u rs t u d y
because they tend to experience greater practice mobility
[29] and report more impediments to practice [30] than
their more experienced counterparts. Unfortunately, the
accuracy of very rare syndrome-positive ICD-9 codes,
such as cutaneous and pulmonary anthrax (22.0 and
22.1), could not be estimated because, as expected, they
were not present in any of the 1,098 participating physi-
cians’ claims during the 2-year study period.
Conclusions
We found that diagnostic codes in physician claims from
community healthcare settings have low sensitivity, mod-
erate to high PPV, and near-perfect specificity and NPV
for identifying 5 syndromes (fever, gastrointestinal, neuro-
logical, rash, and respiratory, including ILI). Future
research should evaluate the practical implications of our
findings on decision-making in response to alerts from
existing syndromic surveillance systems. Future research
should also identify physician, patient, and encounter
characteristics associated with better accuracy of diagnos-
tic codes in physician claims. This would enable public
health to improve syndromic surveillance, either by focus-
ing on physician claims whose diagnostic code is more
likely to be accurate, or by using all physician claims and
weighing each according to the likelihood that its diagnos-
tic code is accurate. We also estimated the prevalence and
PPV of individual diagnostic codes within each syndrome.
We found that rarely used diagnostic codes had a higher
probability of being false-positives, and that more
commonly used diagnostic codes had a higher PPV.
These findings may be useful to the ongoing development
of sensitive and specific consensus syndrome definitions,
as either a sensitive or a specific definition may be more
useful depending on the surveillance objective.
Additional material
Additional file 1: Positive predictive value of individual ICD-9 codes
within each syndrome case definition. For all 12 syndrome case
definitions investigated, the positive predictive value of diagnoses in
physician claims is provided for each individual ICD-9 code.
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